VYALEV is the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor fluctuations in advanced Parkinson's disease
India has been declared ‘functional’ against all the core regulatory functions of the WHO Global Benchmarking Tool Version VI
The partnership marks a pivotal step towards developing new therapies for combating Sickle Cell Disease
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
Developed in consultation with clinicians and patients for an enhanced user experience
Potential of Ayurveda’s contribution in global health system through various innovative practices
India has taken the lead in recognising NAFLD as a major non-communicable disease
Quinidine Sulphate helps manage rare irregular heartbeat conditions
NMC to continue its efforts to improve and enhance the quality of medical education in the country
Subscribe To Our Newsletter & Stay Updated
